These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 26884827
1. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement. Zhao H, Jiao Y, Zhang Z. Int J Clin Exp Pathol; 2015; 8(12):15582-90. PubMed ID: 26884827 [Abstract] [Full Text] [Related]
2. Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-[Formula: see text]B Signaling Pathways. Hsiao YT, Fan MJ, Huang AC, Lien JC, Lin JJ, Chen JC, Hsia TC, Wu RS, Chung JG. Am J Chin Med; 2018; 46(1):209-229. PubMed ID: 29402127 [Abstract] [Full Text] [Related]
3. Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2. Zhao D, Han W, Liu X, Cui D, Chen Y. Thorac Cancer; 2017 Jul; 8(4):320-327. PubMed ID: 28509438 [Abstract] [Full Text] [Related]
4. Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro. Shang HS, Chang JB, Lin JH, Lin JP, Hsu SC, Liu CM, Liu JY, Wu PP, Lu HF, Au MK, Chung JG. Molecules; 2014 Oct 15; 19(10):16588-608. PubMed ID: 25322282 [Abstract] [Full Text] [Related]
5. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines. Chen QY, Jiao DM, Yao QH, Yan J, Song J, Chen FY, Lu GH, Zhou JY. Int J Oncol; 2012 May 15; 40(5):1561-8. PubMed ID: 22266952 [Abstract] [Full Text] [Related]
6. Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway. Li W, Yu X, Ma X, Xie L, Xia Z, Liu L, Yu X, Wang J, Zhou H, Zhou X, Yang Y, Liu H. Cell Signal; 2018 Oct 15; 50():131-141. PubMed ID: 30018008 [Abstract] [Full Text] [Related]
8. Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways. Zhao HJ, Liu T, Mao X, Han SX, Liang RX, Hui LQ, Cao CY, You Y, Zhang LZ. Acta Pharmacol Sin; 2015 Jun 15; 36(6):758-68. PubMed ID: 25864648 [Abstract] [Full Text] [Related]
13. Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro. Huang AC, Yang MD, Hsiao YT, Lin TS, Ma YS, Peng SF, Hsia TC, Cheng YD, Kuo CL, Chung JG. J Ethnopharmacol; 2016 Dec 24; 194():1043-1050. PubMed ID: 27833027 [Abstract] [Full Text] [Related]
14. Suppressive function of low-dose deguelin on the invasion of oral cancer cells by downregulating tumor necrosis factor alpha-induced nuclear factor-kappa B signaling. Liu YP, Lee JJ, Lai TC, Lee CH, Hsiao YW, Chen PS, Liu WT, Hong CY, Lin SK, Ping Kuo MY, Lu PJ, Hsiao M. Head Neck; 2016 Apr 24; 38 Suppl 1():E524-34. PubMed ID: 25784049 [Abstract] [Full Text] [Related]
17. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway. Thamilselvan V, Menon M, Thamilselvan S. Int J Cancer; 2011 Dec 15; 129(12):2916-27. PubMed ID: 21472727 [Abstract] [Full Text] [Related]